Trailing-twelve-month (TTM) revenue is $1.36 Billion with a year-over-year growth of +19.39%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $314,147,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $363,316,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $314,197,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $372,174,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $1,363,834,000 |
Current P/S: $745,272,952 market capitalization ÷ $1,363,834,000 TTM revenue = 0.55x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:35:12.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $372.17M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:37:44.324Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Total Reportable Segments | $1.1B |
| United States Segment | $611M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| BRAZIL | N/A | N/A | N/A | $96M | $104M | N/A |
| Foreign Countries | N/A | N/A |
$1.36B
$1.36 Billion
+19.39%
vs. $1.14B a year ago (TTM)
+4.06%
5 Year compound annual growth rate
1 Year
+19.39%
3 Year
+17.43%
5 Year
+4.06%
10 Year
+4.10%
15 Year
+8.12%
20 Year
+11.03%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.24B | +$116.42M | +10.36% |
| 2024 | $1.12B | +$308.33M | +37.81% |
| 2023 | $815.50M | ($151.03M) | (15.63%) |
| 2022 | $966.52M | ($129.21M) | (11.79%) |
| 2021 | $1.10B | +$30.32M | +2.85% |
| 2020 |
TTM Growth
+19.39%
3-Year CAGR
+17.43%
5-Year CAGR
+4.06%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $229M |
| $255M |
| $421M |
| Other Countries, Outside Of The United States And United Kingdom | $255M | $268M | $264M | N/A | N/A | N/A |
|---|
| UNITED STATES | $677M | $652M | $521M | $358M | $594M | $611M |
|---|
| $1.07B |
| +$70.11M |
| +7.04% |
| 2019 | $995.30M | +$117.34M | +13.37% |
| 2018 | $877.96M | +$56.04M | +6.82% |
| 2017 | $821.92M | ($10.20M) | (1.23%) |
| 2016 | $832.12M | ($109.89M) | (11.67%) |
